Raday Gilead
- SEC CIK
- 0002113137
In the past year, 2 open-market sale filings worth $1.41K and no purchases.
Current role at each company
- RDHL RedHill Biopharma Ltd.Chief Operating Officeras of Jul 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.41K
- 2 filings
- Net
- −$1.41K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Raday Gilead as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 (view filing)4:03 PM ET | Jul 10 | 3 days | Raday GileadChief Operating Officer | SSale | −14.1M | $0.0001 | −$1.41K | −6.1%218.8M after | |
| Apr 22, 2026 (view filing) | Apr 6 | 16 daysLate | Raday GileadChief Operating Officer | SSale | −15.7M | $0.00 | $0 | −5.7%261.1M after |